Spartan Bioscience seeks creditor protection after COVID-19 rapid test issue arises

43901

Sumary of Spartan Bioscience seeks creditor protection after COVID-19 rapid test issue arises:

  • Smaller font Descrease article font size Larger font Increase article font size The Canadian maker of a rapid COVID-19 test has filed for creditor protection after pausing shipments of the product due to a recently identified issue with the system..
  • The Ottawa-based company says it seeking protection from creditors while it restructures its operations and refines the test performance..
  • Despite the challenges, Spartan says it remains committed to mobile DNA-testing technology in the fight against COVID-19..
  • – Apr 20, 2020 Interim CEO Jennifer Ross-Carriere said Spartan Bioscience is a Canadian company working to protect the health and safety of all Canadians…

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close